Other Income & Expense
Other Charges
Year-over-year, this metric grew by 90.6%, from -$339.00M to -$32.00M. Over 2 years (FY 2023 to FY 2025), Other Charges shows a downward trend with a -20.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests unexpected non-operating costs or one-time financial hits, which can negatively impact net income.
Detailed definition
This metric captures non-operating financial expenses that do not fall under standard categories like interest or taxes....
Peer comparison
Often found in the non-operating section of the income statement; peers may label these as 'other expenses' or 'sundry charges'.
Metric ID:
hon_other_chargesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $409.00M | -$649.00M | -$284.00M | $140.00M | $413.00M | $116.00M | $258.00M | $371.00M | -$81.00M | -$273.00M | -$234.00M | -$305.00M | -$339.00M | -$494.00M | $108.00M | $0.00 | -$32.00M |
| QoQ Change | — | >999% | -258.7% | +56.2% | +149.3% | +195.0% | -71.9% | +122.4% | +43.8% | -121.8% | -237.0% | +14.3% | -30.3% | -11.1% | -45.7% | +121.9% | -100.0% | — |
| YoY Change | — | — | — | <-999% | -65.8% | +163.6% | +140.8% | +84.3% | — | -119.6% | -335.3% | -190.7% | -182.2% | -318.5% | -81.0% | +146.2% | +100.0% | +90.6% |
Range-$649.00M – $413.00M
CAGR+92.0%
Avg YoY Growth<-999%
Median YoY Growth-73.4%
Other Charges at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's other charges?
- Bristol-Myers Squibb (BMY) reported other charges of -$32.00M in Q1 2026.
- How has Bristol-Myers Squibb's other charges changed year-over-year?
- Bristol-Myers Squibb's other charges increased by 90.6% year-over-year, from -$339.00M to -$32.00M.
- What is the long-term trend for Bristol-Myers Squibb's other charges?
- Over 2 years (2023 to 2025), Bristol-Myers Squibb's other charges has grown at a -20.9% compound annual growth rate (CAGR), from $1.16B to -$725.00M.
- What does other charges mean?
- Miscellaneous non-operating financial expenses not classified elsewhere.